Abstract
We provide an overview of what is known about the impact of direct-to-consumer (DTC) advertising of prescription drugs. Specifically, we explore the historical trends that led to the industry's increasing use of this form of promotion. Then, using the published literature to date, we review the impact of DTC advertising on the consumer, the medical profession, and the health care system. We conclude by offering policy suggestions for how the pharmaceutical industry can promote its products more responsibly, how the Food and Drug Administration (FDA) can regulate DTC advertising more effectively, and how the medical and public health communities can educate the public about drug therapies more constructively.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 110-128 |
| Number of pages | 19 |
| Journal | Health Affairs |
| Volume | 19 |
| Issue number | 2 |
| State | Published - 2000 |
Fingerprint
ASJC Scopus subject areas
- Health Policy
- Nursing(all)
- Health(social science)
- Health Professions(all)
Cite this
Direct-to-consumer prescription drug advertising : Trends, impact, and implications. / Wilkes, Michael S.; Bell, Robert A.; Kravitz, Richard L.
In: Health Affairs, Vol. 19, No. 2, 2000, p. 110-128.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Direct-to-consumer prescription drug advertising
T2 - Trends, impact, and implications
AU - Wilkes, Michael S.
AU - Bell, Robert A.
AU - Kravitz, Richard L.
PY - 2000
Y1 - 2000
N2 - We provide an overview of what is known about the impact of direct-to-consumer (DTC) advertising of prescription drugs. Specifically, we explore the historical trends that led to the industry's increasing use of this form of promotion. Then, using the published literature to date, we review the impact of DTC advertising on the consumer, the medical profession, and the health care system. We conclude by offering policy suggestions for how the pharmaceutical industry can promote its products more responsibly, how the Food and Drug Administration (FDA) can regulate DTC advertising more effectively, and how the medical and public health communities can educate the public about drug therapies more constructively.
AB - We provide an overview of what is known about the impact of direct-to-consumer (DTC) advertising of prescription drugs. Specifically, we explore the historical trends that led to the industry's increasing use of this form of promotion. Then, using the published literature to date, we review the impact of DTC advertising on the consumer, the medical profession, and the health care system. We conclude by offering policy suggestions for how the pharmaceutical industry can promote its products more responsibly, how the Food and Drug Administration (FDA) can regulate DTC advertising more effectively, and how the medical and public health communities can educate the public about drug therapies more constructively.
UR - http://www.scopus.com/inward/record.url?scp=0005231055&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0005231055&partnerID=8YFLogxK
M3 - Article
C2 - 10718026
AN - SCOPUS:0005231055
VL - 19
SP - 110
EP - 128
JO - Health Affairs
JF - Health Affairs
SN - 0278-2715
IS - 2
ER -